Uncategorized

Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China

A Franco-Chinese collaboration to better detect the virus and monitor its mutations Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of […]

Bayer, Meiogenix collaborate to accelerate agricultural innovation through the development of unique technologies

Bayer and Meiogenix, a biotech company focused on next-generation breeding technologies, announced today a collaboration to advance agricultural research and development by accelerating the development of Meiogenix’s proprietary technologies related to plant breeding and genome editing applications. This new research collaboration has the potential to deliver much-needed plant health and nutrition improvements to food crops […]

Median Technologies records its best quarterly performance and joins forces with biopharmaceutical companies in the fight against Covid-19.

Sophia Antipolis, France – Median Technologies (ALMDT), The Imaging Phenomics Company®, provides an update on its performance for Q1 2020 and a review of its commitment to tackle Covid-19.  Growth in Q1 revenue and order backlog (unaudited figures) Revenue in the first quarter of 2020 stood at €2.8m, a 47% increase from €1.9m in Q1 […]

HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies

Further expansion of HORAMA gene therapy portfolio to treat Inherited Retinal Dystrophies to lead to second clinical program by 2023 Paris (France) and Leiden (Netherlands), March 18, 2020 – HORAMA SA, a French biotechnology company focusing on gene therapy for the treatment of rare genetic diseases in ophthalmology, announced today an exclusive licensing agreement with […]

Hungary and the Netherlands approve Lipiodol® Ultra Fluid for hysterosalpingography in women undergoing infertility workup

 Villepinte (France) – March 23, 2020 – 06:00pm – Guerbet (GBT), a global leader in medical imaging, has announced that it has received indication approval in Hungary and the Netherlands where Lipiodol® Ultra Fluid is now indicated for hysterosalpingography (HSG) in women undergoing infertility workup. Hungary and the Netherlands are the second and third European […]

Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Company’s strategy for innovation and partnerships

Alexis RIDEAU has recognized experience in the development, negotiation and implementation of strategic partnerships in the life sciences field, particularly in microbiology applied to health and infectious diseases. He also has a good track record in sector analysis, support for innovation funding, and fundraising. DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses […]

DBV Technologies Reports March 31, 2020 Cash Position

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its cash and cash equivalents and its number of outstanding and fully diluted shares as of March 31, 2020. Cash and cash equivalents: Cash and cash equivalents as of March 31, 2020, were €262.4 million, compared to […]

Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer

Industry veteran joins Cellectis leadership team as UCART product pipeline advances in clinical trials April 13, 2020 – New York (N.Y.) – Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), today announced the appointment of Carrie Brownstein, M.D., to the role of […]

CARMAT obtains approval for the reimbursement of its total artificial heart during the US clinical feasibility study

Centers for Medicare & Medicaid Services (CMS) confirms coverage of the device and routine care items and services Paris, May 13, 2020 – 5.45 pm CEST CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, […]